-
Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study Diabetol. (IF 8.2) Pub Date : 2024-02-27 Sirimon Reutrakul, Jason C. Park, J. Jason McAnany, Felix Y. Chau, Kirstie K. Danielson, Bharati Prasad, Andrew Cross, Stephanie Sintetas, Julie Law, Silvana Pannain, Sarida Pratuangtham, Eve Van Cauter, Erin C. Hanlon
-
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment Diabetol. (IF 8.2) Pub Date : 2024-02-27 Mengqi Su, Yilin Hou, Sidong Cai, Wenpeng Li, Yinxia Wei, Run Wang, Min Wu, Mingya Liu, Junlei Chang, Kelaier Yang, Kaihang Yiu, Cong Chen
-
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank Diabetol. (IF 8.2) Pub Date : 2024-02-27 Qiao Jin, Eric S. H. Lau, Andrea O. Luk, Claudia H. T. Tam, Risa Ozaki, Cadmon K. P. Lim, Hongjiang Wu, Elaine Y. K. Chow, Alice P. S. Kong, Heung Man Lee, Baoqi Fan, Alex C. W. Ng, Guozhi Jiang, Ka Fai Lee, Shing Chung Siu, Grace Hui, Chiu Chi Tsang, Kam Piu Lau, Jenny Y. Leung, Man-wo Tsang, Elaine Y. N. Cheung, Grace Kam, Ip Tim Lau, June K. Li, Vincent T. F. Yeung, Emmy Lau, Stanley Lo, Samuel
-
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2024-02-26 Alexandra Coomans de Brachène, Maria Ines Alvelos, Florian Szymczak, Priscila L. Zimath, Angela Castela, Bianca Marmontel de Souza, Arturo Roca Rivada, Sandra Marín-Cañas, Xiaoyan Yi, Anne Op de Beeck, Noel G. Morgan, Sebastian Sonntag, Sayro Jawurek, Alexandra C. Title, Burcak Yesildag, François Pattou, Julie Kerr-Conte, Eduard Montanya, Montserrat Nacher, Lorella Marselli, Piero Marchetti, Sarah
-
Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people Diabetol. (IF 8.2) Pub Date : 2024-02-26 Carolin T. Lehner, Marian Eberl, Ewan Donnachie, Luana F. Tanaka, Gunther Schauberger, Florian Schederecker, Sebastian Himmler, Leonie Sundmacher, Stefanie J. Klug
-
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study Diabetol. (IF 8.2) Pub Date : 2024-02-26 Jonne G. ter Braake, Kelly J. Fleetwood, Rimke C. Vos, Luke Blackbourn, Stuart J. McGurnaghan, Sarah H. Wild, Caroline A. Jackson
-
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study Diabetol. (IF 8.2) Pub Date : 2024-02-22 Jimmy Célind, Maria Bygdell, Rebecka Bramsved, Jari Martikainen, Claes Ohlsson, Jenny M. Kindblom
-
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2024-02-22 Pedro Cardoso, Katie G. Young, Anand T. N. Nair, Rhian Hopkins, Andrew P. McGovern, Eram Haider, Piyumanga Karunaratne, Louise Donnelly, Bilal A. Mateen, Naveed Sattar, Rury R. Holman, Jack Bowden, Andrew T. Hattersley, Ewan R. Pearson, Angus G. Jones, Beverley M. Shields, Trevelyan J. McKinley, John M. Dennis
-
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment Diabetol. (IF 8.2) Pub Date : 2024-02-20 Richard I. G. Holt, Clive S. Cockram, Ronald C. W. Ma, Andrea O. Y. Luk
-
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? Diabetol. (IF 8.2) Pub Date : 2024-02-20 Sophie Béliard, Florian Mourre, René Valéro
-
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial Diabetol. (IF 8.2) Pub Date : 2024-02-19 Heikki Hyöty, Susanna Kääriäinen, Jutta E. Laiho, Gail M. Comer, Wei Tian, Taina Härkönen, Jussi P. Lehtonen, Sami Oikarinen, Leena Puustinen, Michele Snyder, Francisco León, Mika Scheinin, Mikael Knip, Miguel Sanjuan
-
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study Diabetol. (IF 8.2) Pub Date : 2024-02-19 Roderick C. Slieker, Magnus Münch, Louise A. Donnelly, Gerard A. Bouland, Iulian Dragan, Dmitry Kuznetsov, Petra J. M. Elders, Guy A. Rutter, Mark Ibberson, Ewan R. Pearson, Leen M. ’t Hart, Mark A. van de Wiel, Joline W. J. Beulens
-
Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits Diabetol. (IF 8.2) Pub Date : 2024-02-19 Jianxin Zhen, Yuqin Gu, Piao Wang, Weihong Wang, Shengzhe Bian, Shujia Huang, Hui Liang, Mingxi Huang, Yan Yu, Qing Chen, Guozhi Jiang, Xiu Qiu, Likuan Xiong, Siyang Liu
-
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life Diabetol. (IF 8.2) Pub Date : 2024-02-17 Natascia Vedovato, Maria V. Salguero, Siri Atma W. Greeley, Christine H. Yu, Louis H. Philipson, Frances M. Ashcroft
-
Metabolomic and genetic architecture of gestational diabetes subtypes Diabetol. (IF 8.2) Pub Date : 2024-02-17 Kristen Lee, Alan Kuang, James R. Bain, M. Geoffrey Hayes, Michael J. Muehlbauer, Olga R. Ilkayeva, Christopher B. Newgard, Camille E. Powe, Marie-France Hivert, Denise M. Scholtens, William L. Lowe
-
The insulin resistant brain: impact on whole-body metabolism and body fat distribution Diabetol. (IF 8.2) Pub Date : 2024-02-16 Martin Heni
-
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis Diabetol. (IF 8.2) Pub Date : 2024-02-16 Milena Jancev, Tessa A. C. M. Vissers, Frank L. J. Visseren, Arianne C. van Bon, Erik H. Serné, J. Hans DeVries, Harold W. de Valk, Thomas T. van Sloten
-
Feasibility of prevention of type 2 diabetes in low- and middle-income countries Diabetol. (IF 8.2) Pub Date : 2024-02-15 Andre P. Kengne, Ambady Ramachandran
-
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data Diabetol. (IF 8.2) Pub Date : 2024-02-14 Pedro F. Teixeira, Tadej Battelino, Anneli Carlsson, Soffia Gudbjörnsdottir, Ulf Hannelius, Matthias von Herrath, Mikael Knip, Olle Korsgren, Helena Elding Larsson, Anton Lindqvist, Johnny Ludvigsson, Markus Lundgren, Christoph Nowak, Paul Pettersson, Flemming Pociot, Frida Sundberg, Karin Åkesson, Åke Lernmark, Gun Forsander
-
Keeping pace: the primary cilium as the conducting baton of the islet Diabetol. (IF 8.2) Pub Date : 2024-02-14 Olof Idevall-Hagren, Ceren Incedal Nilsson, Gonzalo Sanchez
-
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial Diabetol. (IF 8.2) Pub Date : 2024-02-13 Matthias Blüher, Julio Rosenstock, Josef Hoefler, Raymond Manuel, Anita M. Hennige
-
A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2024-02-13 Mengqi Guo, Han Guo, Jingjing Zhu, Fei Wang, Jianni Chen, Chuan Wan, Yujie Deng, Fang Wang, Lili Xu, Ying Chen, Ran Li, Shikai Liu, Lin Zhang, Yangang Wang, Jing Zhou, Shufa Li
-
Harnessing the power of proteomics in precision diabetes medicine Diabetol. (IF 8.2) Pub Date : 2024-02-12 Nigel Kurgan, Jeppe Kjærgaard Larsen, Atul S. Deshmukh
-
Surveillance of the liver in type 2 diabetes: important but unfeasible? Diabetol. (IF 8.2) Pub Date : 2024-02-09 Sami Qadri, Hannele Yki-Järvinen
-
Epidemiology of heart failure in diabetes: a disease in disguise Diabetol. (IF 8.2) Pub Date : 2024-02-09 Anna G. Hoek, Elisa Dal Canto, Eva Wenker, Navin Bindraban, M. Louis Handoko, Petra J. M. Elders, Joline W. J. Beulens
-
QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts Diabetol. (IF 8.2) Pub Date : 2024-01-24 Rodrigue Garcia, Linda C. Schröder, Marine Tavernier, Elise Gand, Joe de Keizer, Arttu Holkeri, Antti Eranti, Nicolas Bidegain, Benjamin Alos, Juhani Junttila, Paul Knekt, Pierre Roumegou, Alexandre Gamet, Claire Bouleti, Bruno Degand, Stéphanie Ragot, Samy Hadjadj, Aapo L. Aro, Pierre-Jean Saulnier
-
Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study Diabetol. (IF 8.2) Pub Date : 2024-01-22
Abstract Aims/hypothesis This register-based study aimed to describe autoimmune comorbidity in children and young adults from type 1 diabetes onset, and to investigate whether such comorbidity was associated with a difference in HbA1c or mortality risk compared with children/young adults with type 1 diabetes without autoimmune comorbidity. Methods A total of 15,188 individuals from the Swedish National
-
Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study Diabetol. (IF 8.2) Pub Date : 2024-01-19 Peter J. Raubenheimer, Joanna Skelton, Bukiwe Peya, Joel A. Dave, Naomi S. Levitt
-
Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns Diabetol. (IF 8.2) Pub Date : 2024-01-18 Mingwei Shao, Duo Chen, Qingzhu Wang, Feng Guo, Fangyi Wei, Wei Zhang, Tian Gan, Yuanyuan Luo, Xunjie Fan, Peijie Du, Yanxia Liu, Xiaojun Ma, Gaofei Ren, Yi Song, Yanyan Zhao, Guijun Qin
-
Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2024-01-18 Karoliina Tuomela, Megan K. Levings
-
Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study Diabetol. (IF 8.2) Pub Date : 2024-01-18 Edward W. Gregg, Haiying Chen, Michael P. Bancks, Raoul Manalac, Nisa Maruthur, Medha Munshi, Rena Wing
-
Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium Diabetol. (IF 8.2) Pub Date : 2024-01-18 Margaretha M. Visser, Astrid Van Muylder, Sara Charleer, John J. Isitt, Stéphane Roze, Christophe De Block, Toon Maes, Gerd Vanhaverbeke, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Jeroen Luyten, Pieter Gillard, Nick Verhaeghe
-
Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α Diabetol. (IF 8.2) Pub Date : 2024-01-13 Beibei Liu, Di Xie, Xinmei Huang, Sungho Jin, Yangyang Dai, Xiaoli Sun, Da Li, Anton M. Bennett, Sabrina Diano, Yingqun Huang
-
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children Diabetol. (IF 8.2) Pub Date : 2024-01-12
Abstract Aims/hypothesis Type 1 diabetes is an autoimmune disorder that is characterised by destruction of pancreatic beta cells by autoreactive T lymphocytes. Although islet autoantibodies (AAb) are an indicator of disease progression, specific immune biomarkers that can be used as target molecules to halt development of type 1 diabetes have not been discovered. Soluble immune checkpoint molecules
-
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2024-01-12 Sandra Hummel, Sarah Rosenberger, Thekla von dem Berge, Rachel E. J. Besser, Kristina Casteels, Angela Hommel, Olga Kordonouri, Helena Elding Larsson, Markus Lundgren, Benjamin A. Marcus, Mariusz Oltarzewski, Anne Rochtus, Agnieszka Szypowska, John A. Todd, Andreas Weiss, Christiane Winkler, Ezio Bonifacio, Anette-G. Ziegler
-
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia Diabetol. (IF 8.2) Pub Date : 2024-01-12 Hamzah Alzubaidi, Vitor H. Oliveira, Catarina Samorinha, Kevin Mc Namara, Jonathan E. Shaw
-
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study Diabetol. (IF 8.2) Pub Date : 2024-01-11 Nikki C. C. Werkman, Gema García-Sáez, Johannes T. H. Nielen, Jose Tapia-Galisteo, Francisco J. Somolinos-Simón, Maria E. Hernando, Junfeng Wang, Li Jiu, Wim G. Goettsch, Carla J. H. van der Kallen, Annemarie Koster, Casper G. Schalkwijk, Hein de Vries, Nanne K. de Vries, Simone J. P. M. Eussen, Johanna H. M. Driessen, Coen D. A. Stehouwer
-
NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function Diabetol. (IF 8.2) Pub Date : 2024-01-11 Sharon Baumel-Alterzon, Liora S. Katz, Luca Lambertini, Isabelle Tse, Fatema Heidery, Adolfo Garcia-Ocaña, Donald K. Scott
-
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy Diabetol. (IF 8.2) Pub Date : 2024-01-08 Roshan Dhanapalaratnam, Tushar Issar, Alexandra T. K. Lee, Ann M. Poynten, Kerry-Lee Milner, Natalie C. G. Kwai, Arun V. Krishnan
-
Remission of type 2 diabetes: always more questions, but enough answers for action Diabetol. (IF 8.2) Pub Date : 2024-01-08
Abstract The concept of type 2 diabetes remission is evolving rapidly, and gaining wide public and professional interest, following demonstration that with substantial intentional weight loss almost nine in ten people with type 2 diabetes can reduce their HbA1c level below the diagnostic criterion (48 mmol/mol [6.5%]) without glucose-lowering medications, and improve all features of the metabolic syndrome
-
Type 2 diabetes and succinate: unmasking an age-old molecule Diabetol. (IF 8.2) Pub Date : 2024-01-05
Abstract Beyond their conventional roles in intracellular energy production, some traditional metabolites also function as extracellular messengers that activate cell-surface G-protein-coupled receptors (GPCRs) akin to hormones and neurotransmitters. These signalling metabolites, often derived from nutrients, the gut microbiota or the host’s intermediary metabolism, are now acknowledged as key regulators
-
Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018 Diabetol. (IF 8.2) Pub Date : 2024-01-05 Nolwenn Regnault, Elodie Lebreton, Luveon Tang, Sandrine Fosse-Edorh, Yaya Barry, Valérie Olié, Cécile Billionnet, Alain Weill, Anne Vambergue, Emmanuel Cosson
-
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review Diabetol. (IF 8.2) Pub Date : 2024-01-04 Rabeeyah Ahmed, Russell J. de Souza, Vincent Li, Laura Banfield, Sonia S. Anand
-
The impact of taxing sugar-sweetened beverages on diabetes: a critical review Diabetol. (IF 8.2) Pub Date : 2024-01-04 José L. Peñalvo
-
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion Diabetol. (IF 8.2) Pub Date : 2023-12-21 Nikhil R. Gandasi, Rui Gao, Lakshmi Kothegala, Abigail Pearce, Cristiano Santos, Samuel Acreman, Davide Basco, Anna Benrick, Margarita V. Chibalina, Anne Clark, Claudia Guida, Matthew Harris, Paul R. V. Johnson, Jakob G. Knudsen, Jinfang Ma, Caroline Miranda, Makoto Shigeto, Andrei I. Tarasov, Ho Yan Yeung, Bernard Thorens, Ingrid W. Asterholm, Quan Zhang, Reshma Ramracheya, Graham Ladds, Patrik Rorsman
-
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists Diabetol. (IF 8.2) Pub Date : 2023-12-21 Gianluigi Savarese, Felix Lindberg, Gerasimos Filippatos, Javed Butler, Stefan D. Anker
-
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study Diabetol. (IF 8.2) Pub Date : 2023-12-20 Arunkumar Krishnan, Carolin V. Schneider, Yousaf Hadi, Diptasree Mukherjee, Bandar AlShehri, Saleh A. Alqahtani
-
Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research Diabetol. (IF 8.2) Pub Date : 2023-12-15 Jeremy Basset-Sagarminaga, Tineke van de Weijer, Patricia Iozzo, Patrick Schrauwen, Vera Schrauwen-Hinderling
-
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial Diabetol. (IF 8.2) Pub Date : 2023-12-14 Matthias Blüher, Julio Rosenstock, Josef Hoefler, Raymond Manuel, Anita M. Hennige
-
Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies Diabetol. (IF 8.2) Pub Date : 2023-12-14 Frida Emanuelsson, Shoaib Afzal, Niklas R. Jørgensen, Børge G. Nordestgaard, Marianne Benn
-
MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial Diabetol. (IF 8.2) Pub Date : 2023-12-05 Yoriko Heianza, Tao Zhou, Xuan Wang, Jeremy D. Furtado, Lawrence J. Appel, Frank M. Sacks, Lu Qi
-
Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas Diabetol. (IF 8.2) Pub Date : 2023-12-05 Sarah Meulebrouck, Victoria Scherrer, Raphaël Boutry, Bénédicte Toussaint, Emmanuel Vaillant, Aurélie Dechaume, Hélène Loiselle, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Morgane Baron, Martine Vaxillaire, Mehdi Derhourhi, Mathilde Boissel, Philippe Froguel, Amélie Bonnefond
-
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective Diabetol. (IF 8.2) Pub Date : 2023-12-02 Johan Jendle, Peter Adolfsson, Pratik Choudhary, Klemen Dovc, Alexander Fleming, David C. Klonoff, Julia K. Mader, Nick Oliver, Jennifer L. Sherr, Jan Šoupal, Lutz Heinemann
-
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia Diabetol. (IF 8.2) Pub Date : 2023-11-30 Willemijn E. Corpeleijn, Wouter J. de Waal, Henk S. Schipper, Albert Wiegman
-
A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2023-11-29 Christoph M. Mooshage, Dimitrios Tsilingiris, Lukas Schimpfle, Lukas Seebauer, Omar Eldesouky, Taraneh Aziz-Safaie, Anja Hohmann, Stephan Herzig, Julia Szendroedi, Peter Nawroth, Sabine Heiland, Martin Bendszus, Felix T. Kurz, Stefan Kopf, Johann M. E. Jende, Zoltan Kender
-
RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine Diabetol. (IF 8.2) Pub Date : 2023-11-30 Michael G. Miskelly, Andreas Lindqvist, Elena Piccinin, Alexander Hamilton, Elaine Cowan, Bent-Johnny Nergård, Rita Del Giudice, Mtakai Ngara, Luis R. Cataldo, Dmytro Kryvokhyzha, Petr Volkov, Luke Engelking, Isabella Artner, Jens O. Lagerstedt, Lena Eliasson, Emma Ahlqvist, Antonio Moschetta, Jan Hedenbro, Nils Wierup
-
Effects of maternal type 1 diabetes and confounding factors on neonatal microbiomes Diabetol. (IF 8.2) Pub Date : 2023-11-29 Marzena Gajecka, Pawel Gutaj, Katarzyna Jaskiewicz, Malgorzata Rydzanicz, Tomasz Szczapa, Dorota Kaminska, Grzegorz Kosewski, Juliusz Przyslawski, Rafal Ploski, Ewa Wender-Ozegowska
-
Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia Diabetol. (IF 8.2) Pub Date : 2023-11-28 Judit Castillo-Armengol, Flavia Marzetta, Ana Rodriguez Sanchez-Archidona, Christian Fledelius, Mark Evans, Alison McNeilly, Rory J. McCrimmon, Mark Ibberson, Bernard Thorens
-
High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study Diabetol. (IF 8.2) Pub Date : 2023-11-27 Catriona M. Farrell, Alison D. McNeilly, Simona Hapca, Paul A. Fournier, Timothy W. Jones, Andrea Facchinetti, Giacomo Cappon, Daniel J. West, Rory J. McCrimmon
-
Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges Diabetol. (IF 8.2) Pub Date : 2023-11-18 Scott C. Mackenzie, Chris A. R. Sainsbury, Deborah J. Wake